de Ette Vasques, DO
Gynecologic Oncology · Fort Worth, TXNPI 1093743098
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (41.5%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 66.0% of it on its own, with 18 other manufacturers making up the rest. 2025 is the largest year on record at $12,136, more than ten times the $779 reported in 2019.
Across 92 payments — averaging $209.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$13K
- Integra Lifesciences Corporation$4K
- Stryker$981
- AstraZeneca$266
- GSK$219
- Genmab U.S., Inc.$187
- plus $596 from 13 others
What the payments were for
- Consulting fees$3,85020%
- Travel & lodging$3,95921%
- Food & beverage$3,44718%
- Education$8,00042%
- Gifts$150%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 29 | $12,719 |
| Integra Lifesciences Corporation | 16 | $4,302 |
| Stryker | 4 | $981 |
| AstraZeneca | 5 | $266 |
| GSK | 7 | $219 |
| Genmab U.S., Inc. | 3 | $187 |
| Johnson & Johnson(2 entities) | 9 | $169 |
| Astellas Pharma US Inc | 3 | $74 |
| Novartis | 2 | $53 |
| Daiichi Sankyo Inc. | 2 | $52 |
| Eisai Inc. | 2 | $47 |
| Servier Pharmaceuticals LLC | 2 | $39 |
| Merck | 2 | $36 |
| EMD Serono, Inc. | 1 | $29 |
| Lilly USA, LLC | 1 | $26 |
| Sanofi | 1 | $20 |
| Taiho Oncology, Inc. | 1 | $19 |
| Tesaro, Inc. | 1 | $16 |
| Tersera Therapeutics LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$12,213
- INTEGRA$4,500
- CODMAN CERTAS$1,775
- CUSA CLARITY$1,775
- NEURAGEN$1,620
- DERMACELL$714
- SPY TECHNOLOGY$714
- SPY-PHI SYSTEM$246
- CODMAN HAKIM$175
- DURASEAL EXACT SPINAL SEALANT SYSTEM$175
- Enhertu$135
- TIVDAK$125
- JEMPERLI$114
How this compares
$19,271 in reported general payments places this provider in the 80th percentile of 135 gynecologic oncology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 11 | $573 |
| Megestrol Acetate | 13 | $494 |
| Gabapentin | 17 | $305 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 31 | $289 |
| Letrozole | 13 | $257 |
| Tramadol Hcl | 23 | $78 |
| Fluconazole | 11 | $77 |
| Ondansetron OdtOndansetron | 11 | $69 |
| Ondansetron Hcl | 11 | $52 |
Paid to pharmacies, not to this prescriber.
Other gynecologic oncology in Fort Worth
- Reagan StreetFort Worth$280K
- Tiffany RedfernFort Worth$165K
- Christopher LafargueFort Worth$26K
- Noelle ClovenFort Worth$18K
- Graham BrownFort Worth$5K
- Robert ColemanHouston$864K
- Joseph de la GarzaSan Antonio$234K
- Maurie MarkmanHouston$204K
- Dustin MandersDallas$171K
- Antonio Santillan-GomezSan Antonio$162K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.